The combination of netilmicin (Sch 20569) 
Infections produced by gram-negative organisms have been associated with a continued high mortality in spite of the development of new antibiotics (13) . Evidence of a synergistic effect has been well documented in vitro against Pseudomonas aeruginosa with the combination of aminoglycosides and carbenicillin (1, (5) (6) (7) 10) . Netilmicin (Sch 20569), an ethyl derivative of dehydrogenated Cia gentamicin, is active against many gentamicin-resistant members of the Enterobacteriaceae (14; K. P. Fu and H. C. Neu, submitted for publication). In vitro synergy studies were undertaken with this agent to determine if it showed in vitro synergy when combined with agents with which it would be used in clinical settings. It is necessary to clarify if in vitro antagonism would result from the combination ofnetilmicin and clindamycin or netilmicin and chloramphenicol. Netilmicin is the most active aminoglycoside against both susceptible and resistant Escherichia coli and Klebsiella (Fu and Neu, submitted for publication). This agent might be used to treat surgical infections in which antibiotics active against anaerobic bacteria are routinely employed because of the mixed bacterial population. We also wished to compare the synergistic activity of netilmicin and gentamicin when combined with carbenicillin, since netilmicin is less active in vitro against Pseudomonas than is gentamicin.
MATERIALS AND METHODS
Netilmicin and gentamicin were supplied by Schering Corporation. Carbenicillin was a gift from Beecham Laboratories. Chloramphenicol, clindamycin, and cefazolin were obtained from Parke, Davis & Co., Upjohn Company, and Eli Lilly & Company, respectively. All bacterial isolates, from blood, urine, sputum, and wounds, were from patients hospitalized at the Columbia Presbyterian Medical Center in the past 2 years. Susceptibility test methods. Minimal inhibitory concentration (MIC) was determined by a standard twofold agar dilution method using Mueller-Hinton agar (BBL) and with a broth dilution method in Mueller-Hinton broth (BBL) as described previously (6) .
Detection of j8-lactamase. Penicillinase production was tested by agar plate iodometric assay as described by Workman and Farrar (17) . Overnight incubations of isolates tested were streaked onto nutrient agar plates containing 0.2% soluble starch. These plates were then flooded with 3 ml of freshly prepared phosphate-buffered saline (pH 6.4) containing iodine (3 mg/ml), potassium iodine (15 mg/ml), and aqueous penicillin G (50 mg/ml) and observed for 30 min. Penicillinase-producing isolates became rapidly decolorized and surrounded by a transparent colorless zone.
Test for synergy. Synergy was defined according to the following criteria: (i) a reduction of the MIC values of both antibiotics by fourfold or more (5); (ii) any definite concavity of the isobologram obtained by graphing the data (7); (iii) a decrease of 1 log or more in viable cell count occurring at the end of 4 h 511 ANTIMICROB. AGENTS CHEMOTHER.
with the antibiotic combination compared with that obtained with the most active single antibiotic (9, 12) . Partial synergy was defined as a fourfold or greater reduction in MIC values of one compound but less than fourfold reduction in the MIC value of the second compound. Indifference was either no reduction in MIC values or only twofold. Antagonism was defined as fourfold reduction in MIC of either compound.
Tests for synergy were done with antibiotics combined in equal concentrations or at ratios similar to those that would be obtained in the blood after intravenous administration. Checkerboard patterns were used to provide isobolograms.
Killing curves. Bacterial killing studies were carried out in Mueller-Hinton broth with the concentration of one-fourth of the MIC of netilmicin alone and in combination with one-fourth of the MICs of other antibiotics studied. The initial concentration of organisms was approximately 105 viable cells in the early logarithmic growth. Bacterial cultures were placed in Erlenmeyer flasks in a rotary shaker incubator at 37°C. Samples were removed and immediately plated at multiple dilutions on MuellerHinton agar to determine viable cell counts.
RESULTS
Synergistic effect of netilmicin with carbenicillin. The isobologram data of the combination of netilmicin and carbenicillin tested in a checkerboard method are given in Fig. 1 . Synergy of the combined antibiotics against three P. aeruginosa strains one Pseudomonas maltophilia strain as indicated by the reduction in MIC values is shown. This synergy of carbenicillin and netilmicin could be further demonstrated for P. aeruginosa 2960 using a killing curve method (Fig. 2) . The addition of onefourth ofthe MIC concentration ofboth netilmicin (5 ,ug/ml) and carbenicillin (100 ,ug/ml) re- Mg/ml, and netilmicin concentration was 1 25 pg/ml. sulted in more than 2-log decrease in viable bacteria compared to the number of colonyforming units when either agent was used alone.
The overall effect of the combination of netilmicin and carbenicillin against 46 P. aeruginosa isolates is given in Table 1 . There was true synergy in 21 instances and indifference in 17 when the comparison was made in agar. 
FU AND NEU
Since the combination of an aminoglycoside and carbenicillin is often selected before the results of blood cultures are available, we determined the effect of the combination of netilmicin and carbenicillin against other species (Table 2) . Included are examples of the actual results obtained for Pseudomonas. We did not find true synergy for the combination against three E. coli, two Serratia, one Providencia, one Klebsiella, or three enterococcal isolates. In no instance was antagonism encountered.
Comparative susceptibility of P. aeruginosa to netilmicin and gentamicin with varying concentrations of carbenicillin is shown in Fig. 3 and 4. Gentamicin was threefold more active against Pseudomonas than was netilmicin (Fu and Neu, submitted for publication), even in the presence of carbenicillin (1.6 to 12.5 ,ug/ml). A significant increase in the susceptibility ofP. aeruginosa to netilmicin and gentamicin was produced in the presence of increasing concentrations of carbenicillin. But in the presence of 12.5 ,ug or less of carbenicillin per ml, the gentamicin MIC value was always threefold less than the netilmicin MIC value. The activity of netilmicin or gentamicin against netilmicin-resistant and gentamicin-resistant isolates (MIC > 5 ,g/ml) is also shown in Fig. 3 a MIC values were determined by the agar dilution method in Mueller-Hinton agar which had a 1.58 mM calcium content and 0.73 mM magnesium content.
b Total number of isolates tested. e Number of isolates affected by netilmicin in combination with another antibiotic. could synergy be demonstrated. Partial synergy against two isolates and indifference with three was found with the combination of gentamicin and carbenicillin, whereas the carbenicillin and Sch 20569 combination yielded synergy against two, partial synergy against two, and indifference against two. When tested against Pseudomonas isolates with carbenicillin MIC values . 100 jig/ml, the combination of carbenicillin and netilmicin was synergistic against 15, whereas carbenicillin-gentamicin was synergistic against 12. Five of 10 Pseudomonas with an MIC >5 ,ug ofgentamicin per ml and 11 of 18 isolates with a netilmicin MIC >5
,ug/ml were synergistically inhibited by the combination of the aminoglycoside with carbenicillin. It is also evident from Fig. 5 that gentamicin is more active than netilmicin even when combined at the concentration of onefourth of the MIC of carbenicillin.
Synergy of netilmicin with cefazolin. Table  1 shows that only one isolate of the 20 Klebsiella pneumoniae tested was synergistically inhibited with the netilmicin and cefazolin combination. An isobologram for this organism is shown in Fig. 6 . The MIC values of netilmicin and cefazolin alone and in combination are shown in Table 3 . Although true synergy was uncommon, there was a fourfold or more decrease in MIC values against five isolates resistant to cefazolin. The MIC levels were those achievable in man with current dosage systems. The combination of netilmicin with cefazolin at the concentration of one-fourth of the MIC values of each antibiotic showed more than 1-log killing against Klebsiella after 4 h of incubation (Fig. 7) .
Synergistic effect of netilmicin and chloramphenicol. The combination of netilmicin and chloramphenicol tested against E. coli is shown in Fig. 8 . All of the E. coli isolates were sensitive to netilmicin (0.16 to 2.5 ,ug/ml). The combination of netilmicin and chloramphenicol was synergistic against three E. coli isolates with chloramphenicol MIC values greater than 100 ,ug (Fig. 8) but not against four of the isolates with MIC values greater than 100 jig.
Although no synergistic effect was demonstrated in these isolates, more than a 16-fold reduction of MIC values of chloramphenicol was achieved. Antagonism was observed with one isolate that was sensitive to both chloramphenicol and netilmicin. Figure 6 illustrates the isobologram data when netilmicin and chloramphenicol are combined against E. coli. Synergistic effect of netilmicin with clindamycin. An isobologram plot (Fig. 6) of MIC values for an E. coli isolate shows the synergistic inhibition of E. coli by netilmicin and clindamycin. All E. coli isolates tested were sensitive to netilmicin (Fig. 9 ) but resistant to clindamycin (MIC 2 100 ug/ml). The netilmicin and clindamycin combination showed indifference or antagonism in most instances. In comparison, the combination of gentamicin and clindamycin produced no synergy, 1 antagonism, 5 partial synergies, and 14 indifferences against E. coli. No synergy could be demonstrated with a netilmicin-clindamycin (Fig. 9) or gentamicin-clindamycin combination against P. aeruginosa. All P. aeruginosa isolates had clindamycin MIC values higher than 200 ,g and gentamicin MIC values between 0.3 to 5 ,ug/ml. One isolate showed an antagonistic effect of netilmicin-clindamycin, but no antagonism was seen with the gentamicin-clindamycin combination.
Relation of synergism to production of inactivating enzymes. ( 1, 6, 7, 10, 12, 16) . This in vitro synergistic effect has also been shown to be effective in prolonged survival of leukopenic animals (2, 11) . The present study showed that netilmicin, like other aminoglycosides (10), when combined with carbenicillin, had a synergistic effect against P. aeruginosa. At therapeutic concentrations, the combination ofnetilmicin and carbenicillin synergistically inhibited more than 90% of the P. aeruginosa strains tested. The synergy studied in this investigation can be confirned by three criteria; however, not all the isolates against which the combination showed synergy could be confirmed by the kill- Clindamycin has been shown to act synergistically with gentamicin against 90% of E. coli and no P. aeruginosa isolates (8) . The present results showed that the netilmicin-clindamycin combination was synergistic against only 29% of E. coli and against no P. aeruginosa. Like the gentamicin-clindamycin combination, synergism was observed only at concentrations of the agents which were not obtainable in man even though significant decreases of the MIC values of clindamycin were observed. Of impor-
